The Tri-Institutional PhD Program in Computational Biology and Medicine (CBM), established in 2003, seeks to recruit highly qualified students from a broad range of backgrounds for a unique interdisciplinary educational opportunity. CBM trains students to use computational and analytical methods to solve problems in biology and medicine from the protein level to the organ level. The program brings together the exceptional educational and research resources of Cornell University in Ithaca, its Medical College in NYC (Weill Cornell Medical College), and Memorial Sloan-Kettering Cancer Center to provide a unique training opportunity at the forefront of computational biology and biomedical research. The program faculty in CBM is conducting research in a wide range of areas, including biophysics and structural biology; genomics and bioinformatics; modeling and systems biology; neuroscience; and cancer biology.
The Tri-Institutional PhD Program in Chemical Biology (TPCB) was established in 2001 as one of the first graduate programs in the world to focus on research and training at the interface of chemistry and biology. The program is centered among three premier New York City institutions, Weill Cornell Medical College, The Rockefeller University, and the Memorial Sloan Kettering Cancer Center. These campuses combine to create a unique university environment and provide unparalleled scientific opportunities to the next generation of leaders in chemical biology. TPCB students are actively engaged in forefront research and students choose from a broad range of chemical biology research areas based on their skills and interests, from organic synthesis of bioactive small molecules, to mechanistic investigations of macromolecules, to dissection of cellular processes using chemical probes, to in vivo evaluation of novel therapeutics.
This collaborative program of Weill Cornell Medical College, The Rockefeller University, and the Sloan-Kettering Institute is one of the few inter-institutional programs dedicated to joint MD and PhD training. The mission of the program is to bridge the gap between laboratory research and clinical medicine, with a goal of contributing to improved health and enhanced quality of life by reducing disability and death from disease.